Dual antiplatelet therapy after heart attack might be too much for some

New research from Peking Union Medical College found that combining two strong antiplatelet drugs after an acute coronary syndrome was riskier for people already on blood thinners for atrial fibrillation. The trial showed higher bleeding rates without better heart outcomes, challenging the default treatment approach.